Sigilon Therapeutics, Inc. | Business Finance | Business Contracts

Sigilon Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on November 30, 2020)

Form of Non-Statutory Stock Option Agreement (Employees) (Filed With SEC on November 30, 2020)

Form of Non-Statutory Stock Option Agreement (Non-Employee Directors) (Filed With SEC on November 30, 2020)

Form of Underwriting Agreement (Filed With SEC on November 30, 2020)

Third Amended and Restated Investors' Rights Agreement, by and among Sigilon Therapeutics, Inc. and the investors party thereto, dated as of October 23, 2020 (Filed With SEC on November 13, 2020)

Warrant to Purchase Stock, between Sigilon Therapeutics, Inc. and Pacific Western Bank, dated January 24, 2018 (Filed With SEC on November 13, 2020)

Warrant to Purchase Stock, between Sigilon Therapeutics, Inc. and Pacific Western Bank, dated November 7, 2019 (Filed With SEC on November 13, 2020)

Form of Warrant to Purchase Stock, between Sigilon Therapeutics, Inc. and Oxford Finance LLC, dated September 2, 2020 (Filed With SEC on November 13, 2020)

Loan and Security Agreement, by and among Oxford Finance LLC, the Lenders party thereto, and Sigilon Therapeutics, Inc., dated September 2, 2020 (Filed With SEC on November 13, 2020)

Specimen stock certificate evidencing shares of common stock (Filed With SEC on November 13, 2020)

Stock Restriction Agreement, between Sigilon Therapeutics, Inc. and Daniel G. Anderson, dated February 10, 2016 (Filed With SEC on November 13, 2020)

Stock Restriction Agreement, between Sigilon Therapeutics, Inc. and Robert S. Langer, dated February 5, 2016 (Filed With SEC on November 13, 2020)

Sigilon Therapeutics, Inc. (51) | Business Finance (12)